Orion Oyj (ORINY) to Issue Dividend of $0.24 on November 7th

Orion Oyj (OTCMKTS:ORINY) declared a dividend on Saturday, October 5th, NASDAQ reports. Investors of record on Wednesday, October 16th will be paid a dividend of 0.2405 per share on Thursday, November 7th. The ex-dividend date is Wednesday, October 16th.

Orion Oyj Stock Performance

Shares of ORINY stock opened at $28.45 on Monday. The company has a current ratio of 2.39, a quick ratio of 1.29 and a debt-to-equity ratio of 0.31. Orion Oyj has a 12-month low of $17.50 and a 12-month high of $28.55. The business’s 50 day moving average is $25.63 and its two-hundred day moving average is $21.86. The company has a market capitalization of $8.03 billion, a P/E ratio of 32.70 and a beta of 0.21.

Orion Oyj (OTCMKTS:ORINY) last announced its earnings results on Thursday, August 8th. The company reported $0.17 earnings per share (EPS) for the quarter. Orion Oyj had a return on equity of 27.97% and a net margin of 18.08%. The firm had revenue of $332.07 million for the quarter. Analysts expect that Orion Oyj will post 1.26 EPS for the current fiscal year.

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.